Efficacy of Sacral Erector Spinae Plane Block (SESPB) on Postoperative Pain and Catheter-related Bladder Discomfort
NCT ID: NCT06127394
Last Updated: 2024-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2023-11-12
2023-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Is sacral ESPB effective on the pudendal nerve dermatome?
* Is sacral ESPB as useful as pudendal block on CRBD? Participants will be divided into two groups and the first group will receive sacral espb after TUR-p operation and the second group will receive pudendal block. Investigators will be present for 24 hours
* catheter related bladder discomfort
* post-operative pain,
* additional analgesic needs will be questioned and the difference between the two groups will be evaluated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sacral Erector Spinae Plane Block(ESPB) in Lumbar Discectomy
NCT06028100
Sacral Erector Spinae Plane Block in Transurethral Prostate Resection Surgery
NCT06962085
Ultrasound Guided Bilateral Erector Spinae Plane Block in Retropubic Radical Prostatectomy
NCT03413163
ESP Block in Radical Prostatectomy
NCT05170373
Evaluation of Postoperative Quality of Recovery Score in Radical Prostatectomy With Erector Spinae Plane Block
NCT05853133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary and secondary outcomes will be questioned for 24 hours and statistics will be made according to the result.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
espb group
Block will be performed with median technique at the level of sacral 2nd vertebrae.
Sacral ESP Block
Sacral ESPB median approach, 40 ml %0,25 Bupivacaine
pudendal group
Bilateral transperineal block will be performed
Pudendal Block
Bilateral pudendal block, 10 ml %0,25 bupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sacral ESP Block
Sacral ESPB median approach, 40 ml %0,25 Bupivacaine
Pudendal Block
Bilateral pudendal block, 10 ml %0,25 bupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Refused to participate in the study
* Known allergy to local anaesthetic
* Where regional anaesthesia is contraindicated
* With known neurological, haematological or muscular disease
* Patients with infection or anatomical changes in the lumbo-sacral region
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Giresun University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bilge Olgun Keles
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bilge Olgun Keleş
Role: PRINCIPAL_INVESTIGATOR
Giresun University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Giresun Research and Training Hospital
Merkez, Giresun, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2023/07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.